If you haven`t sold the double top on ULTA: https://www.tradingview.com/chart/idea/WGAyuL8G/ nor bought the dip: https://www.tradingview.com/chart/idea/3KxGqU8I/ Now analyzing the options chain and the chart patterns of ULTA Beauty prior to the earnings report this week, I would consider purchasing the 690usd strike price Calls with an expiration date of 2026-3-13, for a premium of approximately $8.20. If these options prove to be profitable prior to the earnings release, I would sell at least half of them.... Read more

If you haven`t sold EH before the previous earnings: https://www.tradingview.com/chart/idea/cCNTwClc/ Now analyzing the options chain and the chart patterns of EH EHang Holdings Limited prior to the earnings report this week, I would consider purchasing the 13usd strike price Calls with an expiration date of 2026-7-17, for a premium of approximately $1.40. If these options prove to be profitable prior to the earnings release, I would sell at least half of them.... Read more

The gold market enters today's session amidst increasing macroeconomic risks. Tensions in various regions remain high, while the USD and oil prices stay elevated, reflecting a shift of capital towards defensive assets. However, the main focus of the market tonight is the US CPI data, a factor that could cause significant volatility for both USD and gold. Although geopolitical risks typically support gold, recent price action shows that each upward move occurs quite slowly while the declines are very strong, indicating that the market is still in a liquidity distribution phase rather than entering a clear upward trend. On the H1 chart, gold has broken the short-term downtrend structure and is moving into the FVG + Fibonacci 0.5–0.618 zone (5188 – 5233). This is a critical liquidity area where the market may experience a bull trap before reversing if buying pressure is not strong enough. Main scenario: If the price... Read more

Key Points: Earnings Date: Results reported on February 26, 2026, for periods ending December 31, 2025. Total Revenue: Q4: $77.1M (+29% YoY); Full Year: $283.1M (+20% YoY). LUPKYNIS Sales: Q4: $74.2M (+29% YoY); Full Year: $271.3M (+25% YoY). Balance Sheet: Cash and investments of $398.0M (up from $358.5M in 2024). Capital Return: Repurchased 12.2M shares for $98.2M in 2025. 2026 Guidance: Total revenue $315M-$325M (+11-15%); LUPKYNIS sales $305M-$315M (+12-16%). The Full Story: Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH), a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of therapeutic drugs, announced its financial results for the three and twelve months ended December 31, 2025, on February 26, 2026. The report painted a picture of a company in a strong growth phase, driven entirely by the performance of its flagship asset, LUPKYNIS. Robust Revenue Growth Driven by LUPKYNIS Total revenue for the fourth quarter of 2025 reached $77.1 million, a substantial... Read more

TSLA- making long downtrend channel on the daily time frame. next levels to watch is $415 for upside breakout. $375 for downside. calls above $400 for an upside move towards top of the channel. below $400 we test $375. high watch... Read more

This chart is intentionally simple. The only indicators shown are volume, volume profile, the 8/13/48 EMAs, and the rising price channel . I’ve also marked a Supply and Demand (SnD) zone between $2.10 and $2.27 . The goal here is to focus on structure and participation , not indicator clutter. Note: I linked the previous NNDM charts. Indicator Legend Green EMA = 48 EMA Pink EMA = 13 EMA Red EMA = 8 EMA Volume Compression Volume has been consistently below both the 20MA and 50MA of volume , which indicates participation has been declining as price has climbed. This does not necessarily invalidate the move, but it tells us something important: the markup phase so far has been driven more by lack of selling pressure than strong buying pressure . Low volume during a climb can work for a while, but eventually the market needs participation to sustain momentum.... Read more

SBC Medical Announces Japan-China Aesthetics Alliance to Capitalize on Medical Tourism Surge Key Points: The Alliance: Medical Corporation Nasukai (Japan, operator of Shonan Beauty Clinic) has formed a strategic alliance with Daibi Medical Aesthetics (Shanghai, China). SBC Medical's Role: SBC Medical supports Nasukai and facilitated the partnership as part of its global consulting strategy. Objectives: Enhance Daibi's service quality via Japanese expertise; boost Shonan Beauty Clinic's brand recognition in China; increase inbound medical tourism to Japan. Market Context: Global medical tourism market projected to reach $62.18B by 2032 (23.0% CAGR). Inbound Growth: Shonan Beauty Clinic saw inbound visits nearly triple from 600 (early 2024) to 1,700 (end of 2025). Infrastructure: Clinic has added Chinese translation tools and renewed multilingual websites to support international patients. The Full Story: SBC Medical Group Holdings Incorporated (Nasdaq: SBC), a global provider of comprehensive consulting and management services to medical corporations, has announced a significant... Read more

If you haven`t bought PATH before the previous rally: https://www.tradingview.com/chart/idea/t1OwDwWY/ Now analyzing the options chain and the chart patterns of PATH UiPath prior to the earnings report this week, I would consider purchasing the 37usd strike price Calls with an expiration date of 2028-1-21, for a premium of approximately $1.55. If these options prove to be profitable prior to the earnings release, I would sell at least half of them.... Read more

The short-term Elliott Wave outlook in Crude Oil (CL) indicates that the cycle from the December 16, 2025 low has advanced as a five-wave impulse. From that low, wave (1) concluded at $66.48, followed by a corrective pullback in wave (2) which ended at $61.12. The commodity then resumed its upward trajectory in wave (3), reaching $77.98, before another retracement in wave (4) that settled at $71.65. The final leg, wave (5), extended sharply and terminated at $119.40, thereby completing wave ((1)) at a higher degree. With this structure in place, the market has now entered a corrective phase in wave ((2)), designed to retrace the cycle that began in December 2025. The internal subdivision of this correction is unfolding as a zigzag pattern. From the $119.40 peak, wave (A) declined impulsively and ended at $76.73. Subsequently, wave (B) has begun to rally, working to correct the cycle from the... Read more

Hi friends, new range created. As always we are looking for the manipulation in to the key level around the range. Don't forget confirmation switch from manipulation phase to the distribution phase to make the setup valid. Stay patient and enter only after change in order flow. If price reaches 50% of the range take partial or full close. 📊 Sharpen your trading Strategy ⚙️ 100% Mechanical System - Complete Strategy 🔁 Daily Bias – Continuation 🔄 Daily Bias – Reversal 🧱 Key Level – Order Block 📉 How to Buy Lows and Sell Highs 🎯 Dealing Range – Enter on pullbacks 💧 Liquidity – Basics to understand 🕒 Timeframe Alignments 🚫 Market Narratives – Avoid traps 🐢 Turtle Soup Master – High reward method 🧘 How to stop overcomplicating trading 🕰️ Day Trading Cheat Code – Sessions 🇬🇧 London Session Trading 🔍 SMT Divergence – Secret Smart Money signal... Read more

Key Points: Rating Change: Morgan Stanley upgraded Garmin (GRMN) to Equal Weight from Underweight. Price Target: Raised to $252 from $195. Rationale: Prior negative thesis has "played out"; 2026 guidance viewed as strong and conservative. 2025 Performance: Record revenue of $7.246B (+15% YoY); Q4 revenue of $2.125B (+17% YoY). 2026 Guidance: Revenue ~$7.9B; Operating Income to exceed $2.0B; Pro Forma EPS ~$9.35. Capital Returns: Dividend increased 17% to $4.20/share; New $500M buyback authorized. The Full Story: Garmin Ltd. (NYSE:GRMN) is enjoying a well-deserved moment in the sun after Morgan Stanley revised its outlook on the company, signaling a shift in market perception. On February 19, the financial services giant upgraded the stock to Equal Weight, moving away from its long-held Underweight stance, while simultaneously raising the price target from $195 to $252. The upgrade is rooted in the belief that the challenges previously cited by the firm have fully materialized,... Read more

After a very strong rise and bullish breakout, USOIL Futures is letting off some steam, but it isn't over, I will show you why. I am looking mainly at the MACD & RSI with a long-term perspective. The RSI entering the overbought range, "super strong," and already retraced lower. The MACD just entered the bullish zone for the first time since March 2024. Back then, it traded above the bullish zone just briefly. USOIL's weekly MACD produced the highest reading this week since July 2022. On a rising wave, since January 2022. The highest reading in more than four years. The signal coming from the MACD & RSI is very strong, it says that there is plenty of room left available for growth. USOIL's previous bull market started after a low in April 2020, at this point both the MACD & RSI hit bottom. As prices started to rise, the... Read more

A fierce geopolitical shockwave sent crude oil prices into overdrive, with values spiking more than 20% overnight to reach $116 per barrel. This explosive growth was a direct consequence of heightened U.S. and Israeli military strikes targeting Iran, which instantly raised the specter of supply disruptions in the Strait of Hormuz. As a vital artery for global energy supplies, any threat to this waterway typically injects a massive risk premium into oil prices, and this instance was no different. The narrative shifted dramatically, however, over the weekend of March 9-10. In a televised interview with CBS News, former President Trump moved to de-escalate the rhetorical temperature, describing the conflict as a "short-term excursion" and predicting its imminent conclusion. For traders who had piled into long positions based on fears of a protracted war, this was the signal to exit. The market swiftly pivoted from frantic buying to aggressive profit-taking, unwinding... Read more

INDEX:BTCUSD Key resistances to watch: $68,400 ; $74,500; $79,000 Key supports to watch: $64,000 , $57,600, $55,700 On the 3-month chart: https://www.tradingview.com/x/V10yMMWS/ Prices remain above the 3M Kijun, which serves as support. If this level breaks and the breakout holds, it would confirm, in the long term, the short-term bear trend seen on the Daily and Weekly charts. The 3M Kijun is not the only level to watch here. It is near the 3M Jan '24 Fair Value Gap, which already served as strong support for Jul - Sept 2024, when prices were strongly rejected to the upside. If prices need to go back to the downside, we could revisit $55,970—the 50% level of the July–September '24 wick, and the top of January-March 2024 Fair Value Gap—before continuing the upward trend. There is also a chance of wicking to $52,590, which is 75% of the wick, and approximately 50% of... Read more